Sir Simon Fraser Campbell, CBE, FRS, FMedSci (born 27 March 1941) is a British chemist.[1]
Simon Campbell | |
|---|---|
| Born | Simon Fraser Campbell March 27, 1941 Lapal, England, United Kingdom |
| Alma mater | University of Birmingham (BSc, PhD) |
| Awards | |
| Scientific career | |
| Institutions | |
| Thesis | Elimination processes in polyfluorocycloalkanes (1966) |
Early life and education
Campbell was born on 27 March 1941 in Lapal, England.[3] He obtained a first-class BSc degree in Chemistry in 1962, a PhD degree in 1965, and an honorary DSc degree in 2004 from the University of Birmingham .
Career
He was President of the Royal Society of Chemistry from 2004 to 2006.[1] He led innovative research, discovering some of the world's best-selling prescription drugs, including sildenafil, amlodipine, and doxazosin.[4] He was visiting lecturer at Universidade de São Paulo.[citation needed] He was a medicinal chemist for Pfizer.[5] He was visiting professor at University of Leeds, and on the advisory board of University of Kent, and University of Bristol.[6]
Awards and honours
Campbell was knighted in the 2015 New Year Honours for services to chemistry,[7][8] having previously been made a Commander of the Order of the British Empire (CBE).